MC
GNMK

Menta Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Menta Capital’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$302K Buy
+46,543
New +$328K 0.13% 300
2015
Q4 		– Sell
-24,310
Closed -$191K – 973
2015
Q3 		$191K Buy
+24,310
New +$225K 0.03% 630
2015
Q2 		– Sell
-28,500
Closed -$370K – 807
2015
Q1 		$370K Buy
+28,500
New +$373K 0.05% 523

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Menta Capital's GNMK Position: Q2 2019 in Review

Menta Capital opened a new position in GenMark Diagnostics, Inc (GNMK) in Q2 2019: 46,543 shares worth $302K. The stake represents 0.13% of the portfolio and ranks #300 among its holdings. This is a return to the name: Menta Capital previously reported a position in GNMK as recently as Q3 2015.

Menta Capital first reported a position in GNMK in Q1 2015 and has held it in 3 quarters since. The position peaked at $370K in Q1 2015. 106 funds tracked by Wall St. Rank hold GNMK as of Q2 2019.

  • Menta Capital held 46,543 shares of GenMark Diagnostics, Inc worth $302K as of Q2 2019.
  • GenMark Diagnostics, Inc was a new Menta Capital position in Q2 2019.
  • GenMark Diagnostics, Inc made up 0.13% of Menta Capital's portfolio in Q2 2019, its #300 holding.
  • Menta Capital first reported a position in GenMark Diagnostics, Inc in Q1 2015 and has held it in 3 quarters since.
  • Menta Capital's GenMark Diagnostics, Inc position peaked at $370K in Q1 2015.
  • 106 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.